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Abstract 
Background: About 13 years since the introduction of antiretroviral therapy (ART) for children living with HIV (CLHIV) 
in Zambia, HIV/AIDS testing and treatment guidelines for children have evolved over the years with limited documen-
tation of long-term trends in the numbers testing HIV positive and initiating ART. We examined trends in HIV testing 
and ART initiation in Zambia.
Methods: We conducted a retrospective cohort study using routinely collected patient level data from 496 health 
facilities across Zambia. We used Poisson regression to derive incident rate ratios and 95% confidence intervals (95% 
CI) for background characteristics and used a Cuzick non-parametric test for trends to test the 13-year trends. Median 
time from testing to ART initiation in days and incidence rates were derived using life tables in survival analysis. We 
used multi-level random effects Poisson regression model to determine variations in time from HIV testing to ART 
initiation by facility.
Results: Overall, the cumulative proportion of the children who tested positive and initiated antiretroviral therapy 
(ART for HIV) from 2004 to 2017 was 69% (n = 99 592). During the period under review proportions of ART initiation 
increased from 52% in 2004–2006 to 97% in 2016–2017 (P < 0.001) and time from testing to ART initiation reduced 
from a median of 17 days IQR (1–161) in 2004 to one day IQR (1–14), P < 0.001 in 2016–2017. CLHIV were 15 times 
more likely to be initiated on ART in 2016-17 compared to period 2004-6 (IRR = 15.2, 95% CI 14.7–15.7). Time to ART 
initiation increased with age and was higher in rural health facilities compared to urban facilities. About 11% of the 
variability in time to ART initiation in children could be attributed to differences between facilities.
Conclusions: The substantial increase in ART initiation and reduction in time to ART initiation among CLHIV identi-
fied in this study, reflects improvements in the paediatric HIV programme in Zambia in relation to health care deliv-
ery and adherence to national testing and treatment guidelines that were adapted from WHO guidelines. However, 
age-related differentials in rates of ART initiation suggests that urgent interventions are needed to sustain and further 
improve programme performance.
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Background
Globally, there are about 37.9 million people living with 
HIV with about 24.5 million receiving antiretroviral 
therapy (ART) [1]. Among these, approximately 1.7 mil-
lion are children under the age of 15 years, with only 54% 
of them receiving ART [1]. In Zambia there are 62, 000 
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children living with HIV (CLHIV) with 79% on ART and 
3000 of them die from AIDS related illnesses annually [1, 
2]. ART was first made available free of charge in Zam-
bia in 2005 [3, 4] and since then treatment of children on 
ART has been based on the World Health Organization 
(WHO) treatment guidelines that are adapted for use 
in country. In 2006 WHO recommended initiating chil-
dren on ART based on clinical staging (3/4) or CD4 + T 
cell counts (< 250 cells/μl/CD4% < 25%) [5]. The guide-
lines were then revised in 2008 recommending ART for 
all children less than 12 months regardless of CD4 count 
[6]. By 2010, WHO further revised the guidelines recom-
mending immediate initiation on ART for all infants and 
children less than 2  years regardless of immunologic or 
clinical thresholds and for all children aged 2–5  years 
with clinical stages 3/4 or CD4 < 750 cells/μl or 25% [6]. 
In 2013, the WHO guidelines were revised to recommend 
immediate treatment for all children < 5 years old [7]. The 
current guidelines (2016) now recommend immediate 
initiation on ART for all HIV infected children regardless 
of age under the test and treat guidelines [8].
These changes in the guidelines have resulted in 
improvements in HIV testing and ART initiation among 
children [9–12]. However children still fall through the 
gaps and present for testing and ART initiation at older 
ages and in late HIV stages [11]. A study of 565 children 
initiating ART from 2004 to 2008 at one urban and two 
rural clinics in Zambia showed that about 50% of chil-
dren started treatment between the ages 5 to 10  years 
[12]. Similar trends were seen in a study in Tanzania from 
2004 to 2011 among children in 26 clinics where children 
were initiated on ART at a median age of 5.2 years [13].
In 2018, 13 years later after the introduction of ART 
in Zambia there are improved HIV testing services and 
better ART availability for CLHIV [14–16]. Studies con-
ducted in sub-populations of children in Zambia have 
shown changes in the baseline characteristics of children 
testing HIV positive and initiating ART [14, 15]. How-
ever, little is known about long-term and country-wide 
characteristics of children diagnosed with HIV and ini-
tiating ART in Zambia. This paper uses national rou-
tine patient data to describe the baseline characteristics 
of children in Zambia from HIV testing to ART initia-
tion and how these characteristics have changed over a 
13-year period.
Methods
Study population
This study was a retrospective cohort study of children 
with records in the Zambian SmartCare data system. 
SmartCare is an electronic patient monitoring system 
which is used in many health facilities across all dis-
tricts in Zambia [17–19]. Each patient is given a unique 
identification number at the first contact with the clinic 
and then subsequent records are entered into the data-
base at each visit to health facility. The patient’s records 
are entered in SmartCare either electronically during the 
visit or after the patient has been attended to by enter-
ing the data from a paper-based patient file. SmartCare 
data is collected for routine patient monitoring but is 
prone to missing data in both the electronic database and 
in paper-based format. A  total of  99,592, children less 
than 15  years of age at the time of HIV diagnosis with 
records in SmartCare regardless of missing data during 
the period under review were included in the analysis.
Clinical procedures
In the Zambian health care system, all children with a 
positive serological test for HIV are eligible for enrolment 
into care. At the initial evaluation visit, a record is taken 
of medical history, physical examination, anthropomet-
ric measurements, socio demographic information and 
determination of WHO disease stage. All CLHIV should 
receive HIV care according to national testing and treat-
ment guidelines which includes, the measurement of 
CD4 + T-cell counts or percentages, haemoglobin levels 
(HB), renal and liver function tests and HIV viral loads 
prior to starting ART. Treatment eligibility is determined 
based on the WHO and/or national treatment guidelines 
in effect at the time of HIV testing. Eligible CLHIV are 
treated with a first-line regimen and asked to return for 
clinical evaluation at week 2, week 4 and then every 3 
months for stable children [20, 21].
Data extraction and analysis
The data for this analysis were extracted from Smart-
Care and saved in Excel (Microsoft Corp, Seattle) format 
for cleaning. The data was then exported to Stata ver-
sion 13 (Stata Corp, College Station, Texas) for analy-
sis. Two date variables were used from the dataset, the 
date of the first HIV positive test result (HIV diagnosis) 
and the date initiated on ART. These dates were used to 
derive the year of HIV test, the year of ART initiation, 
and the time between HIV diagnosis and ART initia-
tion. The time variables were grouped into the following 
year bands: 2004–2006, 2007–2009, 2010–2012, 2013–
2015 and 2016–2017, which roughly correspond to the 
years when Zambia implemented the WHO guidelines 
for ART in children. The ages of the children were cat-
egorised into four categories: those less than 18 months, 
18–59  months, 5–9  years and 10–15  years. In addition 
health facilities were categorised into Hospitals, health 
centres, hospices and health posts as classified by the 
Zambia Health facility listing [18].
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Statistical methods
Duplicate results were removed in Stata using the child’s 
ID, date of birth and relevant variables such as labora-
tory results, pharmacy visit and HIV test dates. For con-
tinuous data, a test for normality was performed and 
data that were not normally distributed were described 
using the median and inter quartile ranges (IQR), while 
normally distributed data were described using means 
and standard deviations. The two baseline characteris-
tics: tested for HIV and initiated on ART were used as 
dependent variables. Frequencies and percentages were 
used for categorical data and the Cuzick non-parametric 
test for trends (which is a Wilcoxon-type test for ordinal 
data) was used to show the changes in proportions test-
ing HIV positive across time for the different levels of 
the explanatory variables. Models for trend testing were 
selected based on type of independent variable. All varia-
bles that were tested for trends were ordinal and had two 
or more categories.
We declared the data as survival data using the time 
from HIV testing to initiation on ART using parametric 
survival analysis to estimate the rate of ART initiation. 
Dates when the child was enrolled into HIV care, the 
date of death for those that died or whether they were put 
on ART or not were used to censor the data in survival 
analysis. Incident rate ratios were derived using Pois-
son regression and a Wald test was used to assess sig-
nificance. Mixed multi-level random effects regression 
modelling was used to show variability of time from HIV 
testing to ART initiation among the children attributable 
to type of facility used at ART initiation. Wald tests were 
used to compare goodness of fit for crude and adjusted 
models.
Cumulative aggregate numbers of children initiating 
ART from the UNICEF’s Stocktaking reports and the 
UNAIDS country reports published during the period 
under review were also compiled and compared to 
SmartCare numbers to validate trends in our analysis.
Results
Participants
A total of 99,592 children were recorded as having a 
positive HIV test result from 496 health facilities across 
Zambia during the period under review. Of these chil-
dren 52% (52,109) were female and 48% (47,483) were 
males. In this analysis a total sampling of all children in 
496 health facilities and 71 districts from all ten prov-
inces of the country with relevant records in SmartCare 
was conducted. Out of the 99,592 children recorded as 
having an HIV positive diagnosis between 2004 and 2017, 
69% (68,630) had records showing they started antiret-
roviral therapy (ART). Overall mortality for the period 
under review was 6% (5817/99,592). Mortality in chil-
dren who tested positive, was 7% before ART initiation 
(2167/31,097) and 5% (3431/68,630) in children after 
initiating ART. In addition, a total of 31% (31,097) of 
children that tested HIV positive had no record in Smart-
Care of ART initiation. For the children with records of 
ART initiation, after ART initiation, additional data on 
weight, height and clinical data are not well recorded or 
were missing in most cases, see Fig. 1.
The median age for HIV testing was 2  years with an 
interquartile range of (IQR) 1 to 4  years. Most of the 
records were from Lusaka (25%), Southern (17%), Cop-
perbelt (21%) and Eastern provinces (10%). Western, 
Northern, Muchinga, Central, North-western and Lua-
pula provinces each contributed less than 10% of the 
records, see Table 1.
HIV testing over time
The percentage of children testing HIV positive in the age 
groups from birth to 17 months and from 18 months to 
4 years was highest in the period between 2007 and 2009 
at 30% but declined steadily over the years. In contrast 
among the 10 to 15 age group, HIV testing was lowest in 
between 2007–2009 at 17% and increased over the years 
to 26% by the end of 2017. Median age at testing has 
remained high over the years with the lowest age at test-
ing being 3  years IQR (1–8) in 2007–2009, see Table  2. 
Of those who tested HIV positive, most children (55%) 
were tested in hospitals in 2004–2006 however, this trend 
reduced to 37% between 2016 and 2017 with increasing 
testing in the other facilities (p-value < 0.001).
Estimation of time‑to‑ART initiation over time
The median time from testing to initiating ART reduced 
from 17 days IQR (1–161) in 2004 to 2006 to one day IQR 
(1–14) in the period 2016–2017. Time to ART initiation 
increased with increasing age of the children with chil-
dren aged from 5 to 9 years taking the longest time to be 
initiated on ART (14 days IQR (1–112) during the same 
period. Hospices had the longest time to ART initiation 
at 28 days IQR (1–357) while health posts had the lowest 
time to initiation at 1-day IQR (1–37) see Table 3.
Children were 15.2 times more likely to be initiated on 
ART in 2016–2017 compared to the period 2004–2006 
(1RR = 15.2, 95% CI 14.7–15.7, p-value < 0.001) after 
adjusting for other variables (sex, province, age at HIV 
test, type of health care facility used). In estimating rates 
of ART initiation, the overall ART initiation rate was esti-
mated at 0.14 per month or 1.68 per year, while the rate 
for ART initiation increased over the reporting period 
from 10 per 100-person months in 2004–2006 to 106 per 
100-person months in 2016–2017. Since 2014 almost all 
children who tested positive for HIV have initiated ART, 
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and the median time for ART initiation has dropped 
from 1 month in 2014 to 1 day in 2017 (Fig. 2). Further-
more, the ART initiation rates reduced with increasing 
age groups from 16 per 100-person months in the young-
est age group, to 14 per 100-person months among chil-
dren aged 10 to 15 years during the same period.
Characteristics of children at ART initiation
Overall, the percentage of children who tested HIV posi-
tive who were initiated on ART increased over the years 
to 97% as of December 2017 from 52% in 2004–2006 
(Table  2). Children from birth to 17  months recorded 
the lowest percentages of ART initiation among all the 
age groups with percentages under 20% over the period 
under review. In contrast, percentages of children initiat-
ing ART among the 10 to 15 age group were highest at 
above 25% with the highest percentage recorded between 
2016 and 2017 (p-value < 0.001 z = 8.93). The proportion 
of children initiating ART in urban districts continued to 
be high over the period under review with initiations in 
urban districts maintaining more than 85% ART initia-
tion rates, see Table 4.
Comparison of national estimates of children initiated 
into care with UNICEF and UNAIDS estimates
Cumulative numbers of all children initiating ART in 
SmartCare over the period under review and aggregate 
Tested HIV positive
99,592
Clinical Assessments
Weight: 1,851
Heamoglobin: 4,324
WHO clinical staging:5,888
Death: 3,431
Total Death: 5,598
Virological Assessments
Viral Load: 4,609
Immunological 
Assessments
CD4 Count: 4,318
Initiated on ART
68,630
Sample lossess
Died: 2,167
Status unknown: 28,795
Fig. 1 Flow diagram showing available records of children from testing to ART initiation from 2004 to 2017 December aged 15 years and below in 
Zambia
Table 1 Baseline characteristics of  children diagnosed 
with HIV from 2004 to 2017 in Zambia
Characteristic Population
N %
Sex
 Female 52,209 52
 Male 47,483 48
Age of the children
 Age at HIV test Median (IQR) 2 (1–4)
Province
 Lusaka 25,343 25
 Copperbelt 20,701 21
 Southern 16,498 17
 Eastern 10,312 10
 Central 7097 7
 North-western 3664 4
 Northern 3160 3
 Luapula 3458 3
 Western 7081 7
 Muchinga 2277 2
 Total 99,592 100
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data reported in stocktaking reports published by 
UNICEF [22–26] and UNAIDS global reports and coun-
try data factsheets [27–31] show similar upward trends 
with minor differences among the data sources see Fig. 3. 
Our data shows slightly higher trends from 2009 to 2013 
and from 2014 to 2017 despite the data coming from a 
percentage of health facilities in the country.
Post regression estimates of time to ART initiation 
from multilevel regression clustering at facility level
The mixed random effects model showed significant 
variability in time to ART initiation by age at ART ini-
tiation and district type depending on the health facility 
used at ART initiation. Generally, time to ART initiation 
increased with an increase in age while it reduced by 25% 
(IRR = 0.117, 95% CI 0.099–0.138) in urban areas com-
pared to rural areas see Table 5.
Discussion
This study describes the baseline characteristics of close 
to 100,000 children who were diagnosed with HIV over 
a 13-year period in facilities using SmartCare across 
Zambia. Our observations suggest that there was a sub-
stantial improvement in childhood HIV health care 
delivery and service uptake over years analysed. This is 
evidenced by improvements in specific parameters such 
time to ART initiation which reduced drastically during 
the same period. The data also  shows the impact of the 
WHO guidelines over time with almost 100% of children 
diagnosed with HIV initiating ART since 2014. The 2013 
and 2016 WHO guidelines which recommended imme-
diate ART initiation for children have been instrumental 
in bringing down the delay in initiating ART, with most 
children now starting ART on the same day they receive 
their HIV diagnosis.
Despite these overall improvements there were lower 
rates of HIV testing and longer times to ART initiation 
for particular groups. Those aged 5–9 had the lowest 
rates of HIV testing and those aged 10–15 took longest 
to initiate ART treatment. Estimations of the numbers of 
children initiated on ART in our study were also found 
to be higher than estimates reported in UNAIDS and 
UNICEF documents. Our data shows that 97% of chil-
dren diagnosed with HIV in 2016–2017 were initiated 
on ART which is higher than the UNAIDS estimation for 
Zambia that showed that 52% of children diagnosed with 
HIV were initiated on ART in 2017 [32]. The reasons 
for these differences were not the primary focus of this 
paper. However, disparity in percentages could be attrib-
uted to the differences in the reporting period and facil-
ity coverage. Our higher percentage is in line with reports 
from the Ministry of Health that showed a 65% increase 
in percentages of people initiating ART between 2016 
and 2017 after the implementation of the test and treat 
strategy [33]. It is possible that our estimates have been 
affected by bias common when using routinely collected 
Table 2 Baseline characteristics of children at HIV positive diagnosis in Zambia from 2004 to 2017
IQR interquartile range
*Tested using cuzick non-parametric test for trends
Characteristic 2004/2006
n = 12,087
2007/2009
n = 30,848
2010/2012
n = 2917
2013/2015
n = 2028
2016/2017
n = 7212
P‑value*
Age n (%) < 0.001
 Birth–17 months 1860 (16) 8948 (30) 8140 (28) 4499 (23) 1546 (22)
 18 months–4 years 3391 (29) 8936 (30) 7976 (28) 5431 (28) 1872 (27)
 5–9 years 3740 (32) 7074 (23) 6989 (24) 5183 (26) 1798 (26)
 10–15 years 2788 (24) 5227 (17) 5483 (19) 4535 (23) 1823 (26)
 Median age (IQR) 6 (2–10) 3 (1–8) 4 (1–9) 5 (2–10) 5 (2–11)
Sex n (%) < 0.001
 Male 5868 (49) 15,018 (49) 13,740 (47) 9446 (47) 3411 (47)
 Female 6219 (51) 15,830 (51) 15,457 (53) 10,802 (53) 3801 (53)
Place of testing n (%) < 0.001
Hospital 6682 (55) 16,990 (55) 13,383 (46) 7759 (38) 2658 (37)
Health Centre 5393 (45) 13721 (44) 15477 (53) 12,149 (60) 4217 (58)
District type n (%) < 0.001
 Rural 811 (7) 3 791 (12) 4 538 (16) 3 395 (17) 836 (12)
 Urban 11,276 (93) 27,057 (88) 24,659 (83) 16,852 (83) 6376 (88)
ART initiation status n (%) < 0.001
Initiated on ART 6217 (52%) 16,940 (55%) 19,780 (68%) 18,768 (93%) 6925 (97%)
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data such as missing and incomplete records, as shown 
in the drop in the number children that were diagnosed 
with HIV from a peak of 31,602 between 2007 and 2009 
to only 7270 in 2016/17. This bias included loss in sample 
size leading to only complete case analysis and possibly 
under or over estimation of estimates [34]. We propose 
that this could have been due to effective PMTCT pro-
grams that led to 96% of pregnant women living with 
HIV receiving ART and a more than 50% reduction in the 
number of HIV positive children born from HIV positive 
women between 2011 and 2012 [35].
There were also challenges in ART initiation when 
disaggregated by age group with time to ART initiation 
increasing with increasing age. In addition, 11% vari-
ability in time taken to ART initiation in factors affect-
ing children at ART initiation could be attributed to type 
of facility used at ART initiation. Our data showed that 
children aged 5 to 9 years had the longest time to ART 
initiation and were less likely to be initiated on ART com-
pared to children from birth to 17  months. This could 
be because until 2016, children above 5 years could only 
be initiated on ART once their CD4 count was below 
350  mmol/l thereby increasing time to ART initia-
tion. Another reason for the delay could be some AIDS 
defining conditions like TB that have overlapping symp-
toms and require initiation of ART after treatment of 
Table 3 Incidence rate ratios time from testing to ART and incident rates of children living with HIV in Zambia from 2004 
to 2017
IQR Interquartile range, CI Confidence interval
*Tested using Poisson
Characteristic Number 
initiating ART 
Median time from Test 
to ART in days (IQR)
Rates of ART 
initiation 100 
per month
Person time 
in years
Unadjusted test 
to ART IRR (CI)*
Adjusted 
from test to ART 
IRR (CI)*
Sex
 Male 33,211 10 (1–77) 14 18,909 1 1
 Female 35,419 8 (1–77) 13.6 20,943 0.95 (0.93–0.96) 0.94 (0.93–0.95)
Years
 2004–2006 6217 17 (1–161) 7 9052 1 1
 2007–2009 16,940 11 (1–111) 10 14,972 1.36 (1.32 –1.39) 1.34 (1.31–1.38)
 2010–2012 19,780 10 (1–90) 15 10,823 1.98 (1.92 –2.02) 2.02(1.96 –2.07)
 2013–2015 18,768 9 (1–50) 33 3777 4.55 (4.43–4.67) 4.62 (4.50 –4.74)
 2016–2017 6925 1 (1–14) 106 421 14.5 (13.9–14.9) 15.2 (14.7–15.7)
Age group at test
 Birth to 17 months 12,141 1 (1–55) 16 6278 1 1
 18 months to 4 years 18,953 8 (1–73) 14 10,860 0.91 (0.88 –0.92) 0.92 (0.90–0.94)
 5–9 years 18,476 14 (1–112) 12 12,730 0.76 (0.74–0.77) 0.78 (0.76–0.80)
 10–15 years 17,215 13 (1–77) 14 9898 0.86 (0.84–0.87) 0.86 (0.84 –0.88)
Health facility type
 Hospital 31,776 7 (1–87) 12 20,878 1 1
 Health centre 36,177 13 (1–69) 16 18,352 1.26 (1–1.27) 0.99 (0.97–1.01)
 Hospice 473 28 (1–357) 10 502 0.64 (0.58– 0.70) 0.42 (0.38–0.46)
 Health post 133 1 (1–37) 14 118 1.14 (0.99 –1.31) 0.69 (0.60–0.80)
Province
 Central 5174 1 (1–42) 21 1977 1 1
 Luapula 2677 1 (1–13) 24 880 1.22 (1.16 –1.27) 1.06 (1.01–1.11)
 Copperbelt 15,423 1 (1–46) 14 8865 0.67 (0.65 –0.70) 0.59 (0.57–0.61)
 Eastern 6758 14 (1–115) 11 4734 0.55 (0.53–0.57) 0.45 (0.44–0.47)
 Lusaka 17,886 19 (1–84) 12 11,114 0.62 (0.60 –0.63) 0.62 (0.61–0.64)
 Muchinga 1340 1 (1–18) 18 599 0.89 (0.84 –0.94) 0.80 (0.76–0.85)
 North-western 2599 3 (1–58) 15 1354 0.73 (0.69 – 0.76) 0.61 (0.58–0.64)
 Northern 2681 1 (1–17) 19 1129 0.93 (0.89 – 0.97) 0.69 (0.66–0.72)
 Southern 9424 18 (1–136) 11 6684 0.57 (0.55 – 0.58) 0.54 (0.52–0.56)
 Western 4668 16 (1–91) 14 2513 0.72 (0.69 – 0.74) 0.57 (0.54–0.59)
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the condition is tolerated [36–39]. In addition, children 
above 5 have less contact with the health facilities after 
completion of the Mother and child health (MCH) clinics 
immunization and growth monitoring schedule. There-
fore, diagnosis for this age group is more likely after pre-
senting with acute illness at health facilities [39]. Another 
area with challenges is the testing related dynamics where 
children aged 10 to 15 years had the lowest rates of HIV 
testing. This could be because until recently long-term 
survival of children not on ART following MTCT were 
thought to be uncommon and so testing strategies for 
this age group were not emphasized or were less robust 
[10, 39]. Most children in our study were tested in hospi-
tals in 2004–2006. However, this trend reduced between 
2015 and 2017 with increasing testing in the other facili-
ties types such as hospice and health posts showing 
the need for increased EID services at all health facility 
types [40]. We also found that more female children were 
tested over the study period. Reasons or this are beyond 
the scope of this study. However, sex related differentials 
among children testing for HIV have been reported in 
earlier studies in Zambia which showed more males test-
ing for HIV among hospitalised children [10].
Strengths and limitations
To our knowledge, this paper is the first to show long 
term changes in the characteristics of HIV infected chil-
dren from facilities across Zambia using routinely col-
lected SmartCare data. The main strength of this study 
is the large sample size and the long follow up period 
which makes our findings generalizable to the whole 
population. In addition, we analysed data from public, 
private, military and faith-based health facilities that uti-
lize SmartCare at different levels of the health care deliv-
ery system. Our analysis was merely descriptive which 
made it difficult to attribute causality and a more robust 
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analysis is required to understand the trends in diagnosis 
and initiation onto ART.
The incidence of children initiating ART decreased 
with increasing age, showing the need to promote com-
munity-based programs for routine HIV testing in chil-
dren above 5  years. Facility-based same-day test and 
treat should also be supported to reduce the drop out 
of children between HIV diagnosis and ART initiation. 
The magnitude of missing data may have been small for 
an epidemiological analysis but is alarming if proper 
patient follow-up and care is to be achieved. The Min-
istry of Health needs to ensure data capturing moni-
toring and reporting are easier for health facilities to 
complete in order to improve levels of data complete-
ness, accuracy and quality.
Table 4 Baseline characteristics of children ART initiation in Zambia from 2004 to 2017
IQR interquartile range
*Tested using cuzick non-parametric test for trends
Characteristic 2004/2006
n = 6217
2007/2009
n = 16,940
2010/2012
n = 19,780
2013/2015
n = 18,768
2016/2017
n = 6925
P‑value*
Age n (%) < 0.001
 Birth–17 months 467 (8) 2735 (16) 3 393 (17) 2 495 (14) 876 (13)
 18 months–4 years 1622 (26) 5235 (31) 5891 (30) 4846 (27) 1706 (26)
 5–9 years 2137 (35) 4625 (27) 5282 (27) 5379 (30) 1840 (28)
 10–15 years 1942 (31) 4230 (25) 4945 (25) 5468 (30) 2240 (34)
 Median age (IQR) 7 (4–10) 5 (2–10) 5 (2–10) 7 (2–11) 7 (3–12)
Sex n (%) < 0.001
 Male 3085 (50) 8475 (50) 9569 (48) 8767 (47) 3273 (47)
 Female 3103 (50) 8446 (50) 10,192 (52) 9976 (53) 3641 (53)
Place of testing n (%) < 0.001
 Hospital 3178 (51) 8983 (53) 9188 (47) 7774 (41) 2592 (37)
 Health centre 3002 (49) 7854 (46) 10,477 (53) 10,698 (57) 4105 (59)
District type n (%)
 Rural 394 (6) 1981 (12) 2849 (14) 2807 (15) 854 (12) < 0.001
 Urban 5794 (94) 14,940 (88) 16,912 (86) 15,936 (85) 6060 (88)
Fig. 3 UNICEF and UNAIDS reported numbers vs SmartCare numbers of children on ART over the years
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Conclusion
WHO has spearheaded the fight against HIV and AIDS 
providing guidelines for both testing and treatment of 
CLHIV. Zambia has seen substantial increase in pro-
portions of ART initiation among CLHIV and reduc-
tion in time to ART initiation which suggests successful 
implementation of WHO adapted national testing and 
treatment guidelines and improvements in HIV pro-
gramming. These efforts and should be supported as 
they have saved the lives and improved the quality of 
life of CLHIV in Zambia. However, age related prob-
lems with testing suggest that there are critical areas 
that must be targeted for improvements. These prob-
lems might be showing a gap in health system function-
ing associated with access. There is therefore need to 
address this and target hard to reach groups if improve-
ments are to be sustained.
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